Role of Interalesional Bleomycin in Periocular Capillary Hemangioma

Downloads

Published

2021-07-25

Keywords:

.

Dimensions Badge

Issue

Vol. 9 No. 01 (2021): UP JOURNAL OF OPHTHALMOLOGY

Section

Challenges in Management

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

© Author, Open Access. This article is licensed under a CC Attribution 4.0 License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit https://creativecommons.org/licenses/byncsa/4.0/.

Authors

  • Shalini Mohan .
  • Namrata Patal .
  • Anshika Gupta .
  • Sneha Agrawal .
  • Vineeta Gupta .

Abstract

Background: Capillary hemangioma is one of the most common benign orbital tumor of childhood that appears in early childhood. Primary conjunctival capillary hemangioma resolves in majority of cases spontaneously. However, some periocular and conjuctival hemangioma may not regress and require treatment to prevent serious complication and/or to restore cosmesis. There are many therapeutic options available but these tumors do not always respond well to conventional treatment.

Aim: To treat periocular/conjunctival capillary hemangioma by Intralesional bleomycin, a cytotoxic agent.

Results: The Bleomycin (0.5mg/Kg) diluted in normal saline was used in two cases of periocular and conjunctival capillary hemangioma. Comeplete resolution occurred in one case after two injections while other is regressing after two injections. No significant side effects were noted.

How to Cite

1.
Mohan S, Patal N, Gupta A, Agrawal S, Gupta V. Role of Interalesional Bleomycin in Periocular Capillary Hemangioma . UPJO [Internet]. 2021 Jul. 25 [cited 2025 Feb. 23];9(01):23-5. Available from: https://upjo.org/index.php/upjo/article/view/381

Downloads

Download data is not yet available.